NCT04870307

Brief Summary

The pandemic caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has resulted in substantial global morbidity and mortality including in Oklahoma and caused unprecedented interruptions in nearly all aspects of our lives. The population of the state of Oklahoma is at particular risk to SARS-CoV-2 due to its large rural population, strained healthcare system, and poor overall health. The Community-Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations (CATCH-UP) program will involve both practice-based and community-based approaches to maximize the reach of the Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP) consortium, broaden the potential perspectives that could be captured, and compare the effectiveness of strategies. The interventions will be pragmatic to allow CATCH-UP to respond to changing attitudes, barriers, and environments as the pandemic progresses as well as expected technology developments to produce more effective viral testing that can provide rapid results to patients. The investigators will assist 50 small primary care practices to implement guidelines-based testing and patient education about Coronavirus Disease 2019 (COVID-19) and risk mitigation strategies. The project's community-based approach is designed to rapidly respond to community testing needs by deploying mobile testing sites that will provide operational support to increase the efficiency and the existing capacity for state-wide testing by Oklahoma's public health authorities. Together, the investigators estimate that the CATCH-UP program will result in at least 105,000 SARS-CoV-2 tests performed during the first year of implementation. A comprehensive, ongoing evaluation will be performed to analyze patient and provider attitudes, barriers and facilitators of viral testing, identified health disparities caused by COVID-19, effectiveness of the intervention in both settings, and to allow robust collaboration with other RADx-UP consortium sites.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
323

participants targeted

Target at P50-P75 for not_applicable covid19

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

January 30, 2025

Completed
Last Updated

January 30, 2025

Status Verified

January 1, 2025

Enrollment Period

2.7 years

First QC Date

February 15, 2021

Results QC Date

June 24, 2024

Last Update Submit

January 7, 2025

Conditions

Keywords

COVID-19RADx-UPHealth Services ResearchImplementation ScienceEvidence-based practiceSocial determinants of health

Outcome Measures

Primary Outcomes (7)

  • Change in SARS-CoV-2 Testing Rate (Practices)

    Change in the proportion of patients eligible for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) testing based on screening that receive SARS-CoV-2 test. The proportion ranges between zero and one.

    Baseline to 12 months

  • Change in SARS-CoV-2 Test Positivity Rate

    Change in the proportion of SARS-CoV-2 test results that are positive.

    Baseline to 12 months

  • Barriers to SARS-CoV-2 Testing

    Number (and type) of barriers to SARS-CoV-2 testing reported by practice members based on what they experienced during practice encounters with patients during the study.

    Baseline

  • Barriers to SARS-CoV-2 Testing (Practices)

    Number (and type) of barriers to SARS-CoV-2 testing reported by practice members based on what they experienced during practice encounters with patients during the study.

    Month 3

  • Barriers to SARS-CoV-2 Testing (Practices)

    Number (and type) of barriers to SARS-CoV-2 testing reported by practice members based on what they experienced during practice encounters with patients during the study.

    Month 6

  • Barriers to SARS-CoV-2 Testing (Practices)

    Number (and type) of barriers to SARS-CoV-2 testing reported by practice members based on what they experienced during practice encounters with patients during the study.

    Month 9

  • Barriers to SARS-CoV-2 Testing (Practices)

    Number (and type) of barriers to SARS-CoV-2 testing reported by practice members based on what they experienced during practice encounters with patients during the study.

    Month 12

Secondary Outcomes (8)

  • Change in Influenza Vaccination Rate (NQF #41)

    Baseline to 12 months

  • Change in Pneumococcal Vaccination Rate (NQF #127)

    Baseline to 12 months

  • Change in Zoster Vaccination Rate

    Baseline to 12 months

  • COVID-19 Referrals

    Baseline

  • COVID-19 Referrals

    Month 3

  • +3 more secondary outcomes

Study Arms (1)

Primary Care Practices

OTHER

A practice-based implementation study was conducted with 35 practices, with baseline data collection, and overlapping with interim measurements of care quality and process outcomes, followed by a final data collection at the end of the intervention. Patients were not direct subjects in this part of the study. The intervention targeted practices and practice members.

Other: Dissemination and Implementation Research

Interventions

Dissemination and Implementation research involves assisting primary care practices to address SARS-CoV-2 testing using evidence-based practices as well as increased testing in mobile-based community settings. The D\&I model also involves Practice Assessment, Academic Detailing, Practice Facilitation, Health Information Technology Support, Performance Feedback and Benchmarking, and a Virtual Learning Community.

Primary Care Practices

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Practices:
  • Primary care practices located in Oklahoma.
  • Priority to practices serving a majority of patients that are underserved or vulnerable populations (rural, minority, elderly).
  • Practices routinely using a certified electronic health record (EHR) will be eligible to participate, as practices that are still using paper records are either planning to close due to clinician retirement or will likely be implementing an EHR during the project, which would compromise their ability to participate.
  • Practice-wide participation will be encouraged, but participation of all members within a practice (both clinicians and staff members) will not be required. The minimum acceptable level of participation will be one clinician and nurse/medical assistant dyad plus anyone else who would have to be involved to make changes in the processes of care (e.g. clinic manager) for that unit of care.
  • Clinicians and staff members 18 years of age and older at the time of enrollment (consent).
  • Patients survey participants:
  • Patients (or caregivers of patients) who are seen in eligible practices or community testing sites and received a recommendation for the patient to receive a SARS-CoV-2 diagnostic test.
  • Patients (or their caregivers) who are 18 or older

You may not qualify if:

  • Practices:
  • Practices that are uninterested in reducing missed opportunities for guidelines-based testing for SARS-CoV-2
  • Solo practices with a clinician planning to retire within 12 months of enrollment will not be eligible for participation.
  • Practices likely to experience ownership change in the next 12 months will not be eligible for participation.
  • Patient survey participants:
  • Patients unable to complete the consent process or survey instruments in English or Spanish.
  • Patients or caregivers of patients who are under the age of 18.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma Clinical and Translational Science Institute

Oklahoma City, Oklahoma, 73104, United States

Location

Related Publications (31)

  • CDC COVID-19 Response Team. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):465-471. doi: 10.15585/mmwr.mm6915e4.

    PMID: 32298250BACKGROUND
  • Zhang CH, Schwartz GG. Spatial Disparities in Coronavirus Incidence and Mortality in the United States: An Ecological Analysis as of May 2020. J Rural Health. 2020 Jun;36(3):433-445. doi: 10.1111/jrh.12476. Epub 2020 Jun 16.

    PMID: 32543763BACKGROUND
  • Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam R, Sahu N, Bhatt D, Jones K, Golamari R, Jain R. COVID-19 and Older Adults: What We Know. J Am Geriatr Soc. 2020 May;68(5):926-929. doi: 10.1111/jgs.16472. Epub 2020 Apr 20.

    PMID: 32255507BACKGROUND
  • Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M; SARS-RAS Investigators. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.

    PMID: 32564693BACKGROUND
  • CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.

    PMID: 32240123BACKGROUND
  • Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C). 2020 Apr 19;2020:2402961. doi: 10.34133/2020/2402961. eCollection 2020.

    PMID: 32377638BACKGROUND
  • Turner-Musa J, Ajayi O, Kemp L. Examining Social Determinants of Health, Stigma, and COVID-19 Disparities. Healthcare (Basel). 2020 Jun 12;8(2):168. doi: 10.3390/healthcare8020168.

    PMID: 32545647BACKGROUND
  • Rollston R, Galea S. COVID-19 and the Social Determinants of Health. Am J Health Promot. 2020 Jul;34(6):687-689. doi: 10.1177/0890117120930536b. No abstract available.

    PMID: 32551932BACKGROUND
  • Hawkins D. Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity. Am J Ind Med. 2020 Sep;63(9):817-820. doi: 10.1002/ajim.23145. Epub 2020 Jun 15.

    PMID: 32539166BACKGROUND
  • Terry DL, Woo MJ. Burnout, job satisfaction, and work-family conflict among rural medical providers. Psychol Health Med. 2021 Feb;26(2):196-203. doi: 10.1080/13548506.2020.1750663. Epub 2020 Apr 13.

    PMID: 32281405BACKGROUND
  • Kaufman BG, Whitaker R, Pink G, Holmes GM. Half of Rural Residents at High Risk of Serious Illness Due to COVID-19, Creating Stress on Rural Hospitals. J Rural Health. 2020 Sep;36(4):584-590. doi: 10.1111/jrh.12481. Epub 2020 Jun 30.

    PMID: 32603030BACKGROUND
  • Davoodi NM, Healy M, Goldberg EM. Rural America's Hospitals are Not Prepared to Protect Older Adults From a Surge in COVID-19 Cases. Gerontol Geriatr Med. 2020 Jul 7;6:2333721420936168. doi: 10.1177/2333721420936168. eCollection 2020 Jan-Dec.

    PMID: 32685610BACKGROUND
  • James CV, Moonesinghe R, Wilson-Frederick SM, Hall JE, Penman-Aguilar A, Bouye K. Racial/Ethnic Health Disparities Among Rural Adults - United States, 2012-2015. MMWR Surveill Summ. 2017 Nov 17;66(23):1-9. doi: 10.15585/mmwr.ss6623a1.

    PMID: 29145359BACKGROUND
  • Henning-Smith C, Tuttle M, Kozhimannil KB. Unequal Distribution of COVID-19 Risk Among Rural Residents by Race and Ethnicity. J Rural Health. 2021 Jan;37(1):224-226. doi: 10.1111/jrh.12463. Epub 2020 Jun 25. No abstract available.

    PMID: 32396220BACKGROUND
  • Bavel JJV, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, Crockett MJ, Crum AJ, Douglas KM, Druckman JN, Drury J, Dube O, Ellemers N, Finkel EJ, Fowler JH, Gelfand M, Han S, Haslam SA, Jetten J, Kitayama S, Mobbs D, Napper LE, Packer DJ, Pennycook G, Peters E, Petty RE, Rand DG, Reicher SD, Schnall S, Shariff A, Skitka LJ, Smith SS, Sunstein CR, Tabri N, Tucker JA, Linden SV, Lange PV, Weeden KA, Wohl MJA, Zaki J, Zion SR, Willer R. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020 May;4(5):460-471. doi: 10.1038/s41562-020-0884-z. Epub 2020 Apr 30.

    PMID: 32355299BACKGROUND
  • Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.

    PMID: 32150748BACKGROUND
  • Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, Yuan B, Kinoshita R, Nishiura H. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. J Clin Med. 2020 Feb 17;9(2):538. doi: 10.3390/jcm9020538.

    PMID: 32079150BACKGROUND
  • Furukawa NW, Brooks JT, Sobel J. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic. Emerg Infect Dis. 2020 Jul;26(7):e201595. doi: 10.3201/eid2607.201595. Epub 2020 Jun 21.

    PMID: 32364890BACKGROUND
  • Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin HP, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA; Public Health-Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.

    PMID: 32329971BACKGROUND
  • Tromberg BJ, Schwetz TA, Perez-Stable EJ, Hodes RJ, Woychik RP, Bright RA, Fleurence RL, Collins FS. Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative. N Engl J Med. 2020 Sep 10;383(11):1071-1077. doi: 10.1056/NEJMsr2022263. Epub 2020 Jul 22. No abstract available.

    PMID: 32706958BACKGROUND
  • Dwyer JW, Contreras D, Eschbach CL, Tiret H, Newkirk C, Carter E, Cronk L. Cooperative Extension as a Framework for Health Extension: The Michigan State University Model. Acad Med. 2017 Oct;92(10):1416-1420. doi: 10.1097/ACM.0000000000001640.

    PMID: 28353501BACKGROUND
  • Grumbach K, Mold JW. A health care cooperative extension service: transforming primary care and community health. JAMA. 2009 Jun 24;301(24):2589-91. doi: 10.1001/jama.2009.923. No abstract available.

    PMID: 19549977BACKGROUND
  • Kaufman A, Boren J, Koukel S, Ronquillo F, Davies C, Nkouaga C. Agriculture and Health Sectors Collaborate in Addressing Population Health. Ann Fam Med. 2017 Sep;15(5):475-480. doi: 10.1370/afm.2087.

    PMID: 28893819BACKGROUND
  • Phillips RL Jr, Kaufman A, Mold JW, Grumbach K, Vetter-Smith M, Berry A, Burke BT. The primary care extension program: a catalyst for change. Ann Fam Med. 2013 Mar-Apr;11(2):173-8. doi: 10.1370/afm.1495.

    PMID: 23508605BACKGROUND
  • Chou AF, Homco JB, Nagykaldi Z, Mold JW, Daniel Duffy F, Crawford S, Stoner JA. Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma. BMC Health Serv Res. 2018 Jun 4;18(1):404. doi: 10.1186/s12913-018-3189-4.

    PMID: 29866120BACKGROUND
  • Bodenheimer T, Ghorob A, Willard-Grace R, Grumbach K. The 10 building blocks of high-performing primary care. Ann Fam Med. 2014 Mar-Apr;12(2):166-71. doi: 10.1370/afm.1616.

    PMID: 24615313BACKGROUND
  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.

    PMID: 19664226BACKGROUND
  • Kenney C. Transforming Health Care. Virginia Mason Medical Center's Pursuit of the Perfect Patient Experience.: Productivity Press.; 2010

    BACKGROUND
  • Chao EC. Structured correlation in models for clustered data. Stat Med. 2006 Jul 30;25(14):2450-68. doi: 10.1002/sim.2368.

    PMID: 16220520BACKGROUND
  • van Oest R. A new coefficient of interrater agreement: The challenge of highly unequal category proportions. Psychol Methods. 2019 Aug;24(4):439-451. doi: 10.1037/met0000183. Epub 2018 May 3.

    PMID: 29723005BACKGROUND
  • Cohen DJ, Crabtree BF. Evaluative criteria for qualitative research in health care: controversies and recommendations. Ann Fam Med. 2008 Jul-Aug;6(4):331-9. doi: 10.1370/afm.818.

    PMID: 18626033BACKGROUND

Related Links

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Dr. Juell Homco
Organization
University of Oklahoma Tulsa

Study Officials

  • Judith A James, MD, PhD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Dissemination and Implementation Research (D\&I): Involves assisting primary care practices to address SARS-CoV-2 testing using evidence-based practices as well as increased testing in mobile-based community settings. The D\&I model also involves Practice Assessment, Academic Detailing, Practice Facilitation, Health Information Technology Support, Performance Feedback and Benchmarking, and a Virtual Learning Community.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2021

First Posted

May 3, 2021

Study Start

September 30, 2020

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

January 30, 2025

Results First Posted

January 30, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations